Why We Conduct Research: Standard analgesic treatments (including opioids, tricyclic antidepressants, anticonvulsants, NMDA receptor antagonists, and other ion channel antagonists) have thus far provided inadequate pain relief for patients with central and peripheral neuropathic pain. Recent basic and clinical research have opened the possibility for new pharmacological treatments.
Our Research Focus: The Translational Pain Research program examines how novel drugs, especially non-opioid analgesics, affect different pain mechanisms. Our aim is to develop treatments for acute and chronic pain conditions, including central and peripheral neuropathic pain, migraines, connective tissue disorders, and the arthritides.
Our Research Methods: We identify selective causes of pain in individual patients and match those patients with appropriate therapies that are being evaluated in clinical trials. In addition, we often use experimental pain models to aid our research.
If you are interested in participating or learning more about our research, please contact us.
Sponsors of Our Research Have Included:
National Institute of Neurological Diseases and Stroke (National Institutes of Health)
Christopher Reeve Foundation
Mike Utley Foundation
Paralyzed Veterans of America
Lilly Research Laboratories
Endo Pharmaceuticals, Inc.
Pfizer, Inc.
Johnson & Johnson Subsidiaries
AstraZeneca
Schwarz Pharma
Cogentix, Inc.
Gedeon Richter Ltd.